Work

Lenacapavir: A capsid inhibitor for HIV-1 treatment and prevention

Year: 2025

Type: article

Source: Biochemical Pharmacology

DOI: 10.1016/j.bcp.2025.117125

Authors: Erik De Clercq, Yuya Zhang, Guangdi Li, Yelin Deng, Ricardo Khouri, Daniel Růžek, Ewelina Król, Li Tan

Institutions: Central South University, Rega Institute for Medical Research, KU Leuven, Soochow University, Universidade Federal da Bahia, Fundação Oswaldo Cruz, Masaryk University, Veterinary Research Institute, Institute of Parasitology, Czech Academy of Sciences, Biology Centre, University of Gdańsk, Gdańsk Medical University, Second Xiangya Hospital of Central South University

Language: English

Topic: HIV/AIDS drug development and treatment

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Natural Science Foundation of China, Central South University, Natural Science Foundation of Hunan Province

Awards: G2538739354, G4911769535

OpenAlex ID: W4412048655

FWCI: 10.56

Cites: 63

Cited by: 15

Related to: 10